Nabijon Yuldashev

3 ta ish

Republican Specialized Cardiology Center, Tashkent, Uzbekistan

1. The use of bioresorbable vascular scaffold Absorb BVS® in patients with stable coronary artery disease: one-year results with special focus on the hybrid bioresorbable vascular scaffolds and drug eluting stents treatment

   Robert Gil, Jacek Bil, Tomasz Pawłowski +5

   MaqolaCoronary Interventions and DiagnosticsKardiologia Polska20160 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000135

2. PT130 Analysis of the Causes of Destabilization of Coronary Heart Disease Within 1 Year, Depending on the Presence or Absence of Metabolic Syndrome

   G. Nagaeva, S. Nagaev, Nabijon Yuldashev +1

   MaqolaHealth, Environment, Cognitive AgingGlobal Heart20160 iqtibos

   ABIABI:AkademIndex/openalex/2016.article.000824

3. One-Year Results of the Use of Absorb Bioresorbable Vascular Scaffold in Patients with Different Forms of Coronary Artery Disease as Compared to a Drug-Eluting Stent

   Nabijon Yuldashev, Robert Gil, R. D. Kurbanov

   MaqolaCoronary Interventions and DiagnosticsInternational Journal of Biomedicine20180 iqtibos

   ABIABI:AkademIndex/openalex/2018.article.000491